For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Litigation & Arbitration

May 18, 2023

Walgreens to pay San Francisco $230M over opioid deaths

Elizabeth J. Cabraser, partner at Lieff Cabraser, said Wednesday that this trial and settlement had a ripple effect: defendants around the country, including Walgreens, Teva, Allergan, Walmart and CVS came quickly to the negotiating table and a new set of national settlements were crafted.

San Francisco reached a record-setting $230 million settlement with Walgreens after triumphing in a liability trial regarding the pharmaceutical chain’s role in the opioid crisis, City Attorney David Chiu announced Wednesday.

Senior U.S. District Judge Charles R. Breyer ruled after the 11-week trial that Walgreens, which was the largest dispenser of opioids in San Francisco and the only remaining defendant after other companies settled, sub...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.